pharmacology
New faculty Rick Sando: A better understanding of brain circuitry
Oct. 26, 2020—New Assistant Professor of Pharmacology Rick Sando is interested in how neural circuits carry out specific functions when activated—and why these processes sometimes go awry.
Turning Heads: The Vanderbilt Brain Institute has emerged as a hub of discovery as neuroscience’s influence expands
Aug. 5, 2020—The VBI recently marked its 20th anniversary, a span that has seen the institute’s wide-ranging missions—including administering the university’s Neuroscience Graduate Program, as well as postdoctoral training and community outreach—steadily coalesce under a single umbrella.
Committed to Memory: VU319 may hold the key to improving memory loss in Alzheimer’s patients
Jul. 23, 2020—VU319, an investigational drug product developed by Vanderbilt researchers, targets one of medicine’s most bedeviling challenges: improving memory loss in people with Alzheimer’s disease.
Leader in Vanderbilt drug discovery efforts, Craig Lindsley named interim editor-in-chief of ACS Pharmacology & Translational Science
Jun. 12, 2020—Craig Lindsley, William K. Warren, Jr. Chair in Medicine and university professor of biochemistry, chemistry and pharmacology, has been named interim editor-in-chief of the journal "ACS Pharmacology & Translational Science."
Meet the alpacas that are helping researchers who study autism, Alzheimer’s and cancer
Aug. 13, 2019—Written by Heidi Hall Alpacas aren’t the typical animals that drivers spot as they wind their way through rural Tennessee, but there’s a happy herd of them outside Waverly, where they eat the finest pellets, walk up and down a scenic hill and potentially save lives. They’re owned by a team of Vanderbilt University researchers...
Ancora announces major funding awards to support Vanderbilt drug discovery research
Nov. 26, 2018—Ancora Innovation, LLC, the new collaboration between Vanderbilt and Deerfield Management established earlier this year, has completed its inaugural proposal review process and announced two projects selected for funding.
New faculty: Lisa Monteggia
Nov. 12, 2018—Lisa Monteggia is professor of pharmacology and Barlow Family Director of the Vanderbilt Brain Institute.
Three VU doctoral students receive 2018 Gilliam Fellowships for Advanced Study
Aug. 1, 2018—The Howard Hughes Medical Institute has awarded 2018 Gilliam Fellowships for Advanced Study—created to ensure that a diverse and highly trained workforce is prepared to assume leadership roles in the sciences—to three Vanderbilt University doctoral students and their advisers.
$8.1 million grant funds new center to research highly aggressive form of lung cancer
Jun. 8, 2018—A five-year National Cancer Institute grant will fund an interdisciplinary research center for the study of small cell lung cancer, a highly aggressive, incurable form of the disease.
Vanderbilt earns top rankings, including a No. 1, for successful minority recruitment in master’s and Ph.D. programs
Dec. 12, 2016—"Diverse: Issues In Higher Education" has ranked Vanderbilt University No. 1 in the country for the number of doctoral degrees awarded to African Americans in the biological and biomedical sciences.
New faculty: David Sweatt studies how brain chemistry affects learning and memory
Oct. 13, 2016—Homecoming came early this year for Vanderbilt alumnus David Sweatt, who joined the faculty as chair of Pharmacology this summer, 30 years after receiving his Ph.D. from the department he now leads.
Basic science, extraordinary impact
Oct. 6, 2016—The discoveries that can change the course of human health forever often begin in the tiniest places: in molecules and cells, at the most fundamental intersection of physics, chemistry and biology. Understanding how these cellular and molecular processes work is the focus of basic biomedical research at Vanderbilt.